FDA Approved for Adult Patients with HER2+ unresectable or metastatic breast cancer after two or more prior anti-HER2-based regimens in the metastatic setting! Learn more!
See program details below! Grab a seat!
NEW EVENT THIS THURSDAY! New drug for HER2+ Breast Cancer
This event has been rescheduled to April 26th, 2022. New event info coming soon...